Akt activation and localisation correlate with tumour invasion and oncogene expression in thyroid cancer

被引:188
作者
Vasko, V
Saji, M
Hardy, E
Kruhlak, M
Larin, A
Savchenko, V
Miyakawa, M
Isozaki, O
Murakami, H
Tsushima, T
Burman, KD
De Micco, C
Ringel, MD
机构
[1] Ohio State Univ, Sch Med, Div Endocrinol, Columbus, OH 43210 USA
[2] Ohio State Univ, Sch Med, Div Oncol, Columbus, OH 43210 USA
[3] Arthur G James Canc Ctr, Columbus, OH USA
[4] Washington Hosp Ctr, MedStar Res Inst, Washington, DC 20010 USA
[5] Ctr Endocrine Surg, Kiev, Ukraine
[6] Mediterranean Univ, INSERM, U555, Marseille, France
[7] NCI, NIH, Bethesda, MD 20892 USA
[8] Tokyo Womens Med Univ, Tokyo, Japan
关键词
D O I
10.1136/jmg.2003.015339
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Introduction: Akt activation is involved in the pathogenesis of inherited thyroid cancer in Cowden's syndrome and in sporadic thyroid cancers. In cell culture, Akt regulates thyroid cell growth and survival; but recent data suggest that Akt also regulates cell motility in non-thyroid cell lines. We therefore sought to evaluate the role of Akt in thyroid cancer progression. Methods: We evaluated 46 thyroid cancer, 20 thyroid follicular adenoma, and adjacent normal tissues samples by immunohistochemistry for activated Akt (pAkt), Akt 1, 2, and 3, and p27 expression. Immunoblots were performed in 14 samples. Results: Akt activation was identified in 10/10 follicular cancers, 26/26 papillary cancers, and 2/10 follicular variant of papillary cancers, but in only 4/66 normal tissue samples and 2/10 typical benign follicular adenomas. Immunoactive pAkt was greatest in regions of capsular invasion; and was localised to the nucleus in follicular cancers and the cytoplasm in papillary cancers, except for invasive regions of papillary cancers where it localised to both compartments. Immunoactive Akt 1, but not Akt 2 or Akt 3, correlated with pAkt localisation, and nuclear pAkt was associated with cytoplasmic expression of p27. In vitro studies using human thyroid cancer cells demonstrated that nuclear translocation of Akt 1 and pAkt were associated with cytoplasmic p27 and cell invasion and migration. Cell migration and the localisation of Akt 1, pAkt, and p27 were inhibited by PI3 kinase, but not MEK inhibition. Discussion: These data suggest an important role for nuclear activation of Akt 1 in thyroid cancer progression.
引用
收藏
页码:161 / 170
页数:10
相关论文
共 64 条
[31]   Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome [J].
Liaw, D ;
Marsh, DJ ;
Li, J ;
Dahia, PLM ;
Wang, SI ;
Zheng, ZM ;
Bose, S ;
Call, KM ;
Tsou, HC ;
Peacocke, M ;
Eng, C ;
Parsons, R .
NATURE GENETICS, 1997, 16 (01) :64-67
[32]  
Liu AX, 1998, CANCER RES, V58, P2973
[33]   Carboxyl-terminal modulator protein (CTMP), a negative regulator of PKB/Akt and v-Akt at the plasma membrane [J].
Maira, SM ;
Galetic, I ;
Brazil, DP ;
Kaech, S ;
Ingley, E ;
Thelen, M ;
Hemmings, BA .
SCIENCE, 2001, 294 (5541) :374-380
[34]   Molecular cloning, expression and characterization of the human serine/threonine kinase Akt-3 [J].
Masure, S ;
Haefner, B ;
Wesselink, JJ ;
Hoefnagel, E ;
Mortier, E ;
Verhasselt, P ;
Tuytelaars, A ;
Gordon, R ;
Richardson, A .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1999, 265 (01) :353-360
[35]   LONG-TERM IMPACT OF INITIAL SURGICAL AND MEDICAL THERAPY ON PAPILLARY AND FOLLICULAR THYROID-CANCER [J].
MAZZAFERRI, EL ;
JHIANG, SM .
AMERICAN JOURNAL OF MEDICINE, 1994, 97 (05) :418-428
[36]   Chemoattractant-mediated transient activation and membrane localization of Akt/PKB is required for efficient chemotaxis to cAMP in Dictyostelium [J].
Meili, R ;
Ellsworth, C ;
Lee, S ;
Reddy, TBK ;
Ma, H ;
Firtel, RA .
EMBO JOURNAL, 1999, 18 (08) :2092-2105
[37]   Docking protein FRS2 links the protein tyrosine kinase RET and its oncogenic forms with the mitogen-activated protein kinase signaling cascade [J].
Melillo, RM ;
Santoro, M ;
Ong, SH ;
Billaud, M ;
Fusco, A ;
Hadari, YR ;
Schlessinger, J ;
Lax, I .
MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (13) :4177-4187
[38]   Identification of a chromosome 3p14.3-21.1 gene, APPL, encoding an adaptor molecule that interacts with the oncoprotein-serine/threonine kinase AKT2 [J].
Mitsuuchi, Y ;
Johnson, SW ;
Sonoda, G ;
Tanno, S ;
Golemis, EA ;
Testa, JR .
ONCOGENE, 1999, 18 (35) :4891-4898
[39]   The RFG oligomerization domain mediates kinase activation and re-localization of the RET/PTC3 oncoprotein to the plasma membrane [J].
Monaco, C ;
Visconti, R ;
Barone, MV ;
Pierantoni, GM ;
Berlingieri, MT ;
De Lorenzo, C ;
Mineo, A ;
Vecchio, G ;
Fusco, A ;
Santoro, M .
ONCOGENE, 2001, 20 (05) :599-608
[40]   Identification of a human Akt3 (protein kinase Bγ) which contains the regulatory serine phosphorylation site [J].
Nakatani, K ;
Sakaue, H ;
Thompson, DA ;
Weigel, RJ ;
Roth, RA .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 257 (03) :906-910